ABEO vs CURI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 09, 2026

ABEO

48.0
AI Score
VS
ABEO Wins

CURI

44.2
AI Score

Investment Advisor Scores

ABEO

48score
Recommendation
BUY

CURI

44score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ABEO CURI Winner
Forward P/E 18.6567 8.547 CURI
PEG Ratio 0 0 Tie
Revenue Growth 2745.0% 22.3% ABEO
Earnings Growth 0.0% 1400.0% CURI
Tradestie Score 48.0/100 44.2/100 ABEO
Profit Margin -246.4% 0.0% CURI
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD ABEO

Relative Price Performance (Last 90 Days)

ABEO 1M: -49.9% · 3M: -67.1% CURI 1M: -13.9% · 3M: -13.9%

Current Technical Phase

ABEO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.5%), weak momentum, RSI 19

RSI (14): 18.6 · Price: $2.46

CURI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.0%), weak momentum, RSI 35

RSI (14): 35.2 · Price: $2.41

Fundamentals Snapshot

Metric ABEO CURI
Market Cap — —
Forward P/E -9.4 7.8
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 27.5% 0.2%
Gross Margin 0.0% 0.6%
Operating Margin -1.0% 0.4%
EPS -1.16 0.00
Dividend Yield — 0.13%

Frequently Asked Questions

Based on our detailed analysis, ABEO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.